Novel Psychoactive Substances
| Autor: | M.T. Zanda, L. Fattore |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Drug
medicine.medical_specialty Health professionals business.industry media_common.quotation_subject education 010401 analytical chemistry technology industry and agriculture 01 natural sciences Mental health 0104 chemical sciences 03 medical and health sciences 0302 clinical medicine Regulatory control Synthetic cannabinoids medicine Health risk business Psychiatry Severe toxicity health care economics and organizations 030217 neurology & neurosurgery media_common medicine.drug |
| Popis: | Usually considered as legal replacement for regulated products, novel psychoactive substances (NPS) represent worldwide an underestimate health risk. Freely available on the Internet, NPS are still legal in some countries, advertised as safe substances, and in most cases undetectable by standard drug-screening tests, which renders NPS very popular and appealing to drug users. They typically induce more frequent and severe negative effects than the precursor drug they are supposed to mimic, and are associated with severe toxicity and fatal intoxications. In this chapter we illustrate and discuss the pharmacology and toxicology of the most common classes of NPS, that is, hallucinogens, stimulants, dissociative drugs, prescribed products, and performance- and image-enhancing drugs (PIEDs). Despite growing regulatory control measures, use of NPS is extensive and represents an ever-evolving health and legal concern. Social and health professionals should maintain a high degree of alertness for NPS use and their possible psychiatric effects among vulnerable people. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|